SETMAR and thyroid gland carcinoma: In this study, we identified SETMAR as a differentiation‐related histone methylation modifier in thyroid cancer, and we found that its mRNA was stabilized by METTL3‐mediated m6A modification in an IGF2BP3‐dependent manner.